We will explore whether reducing ZIP8 expression can alleviate inflammation, preserve ECM integrity and mitigate disc degeneration, thus providing a more robust foundation for targeted therapies. This evidence concerns the gene SLC39A8 and intervertebral disk degenerative disorder.